Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients

Stem Cells

Volumn 21, Issue 2, 2003, Pages 200-207

  Askenasy, Nadir ^a   Yoleuk, Esma S ^b   Shirwan, Haval ^b   Wang, Zhiliang ^c   Farkas, Daniel L ^d  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Heart gratis; Hematopoietic chimerism; Isolated limb perfusion; Tolerance

Indexed keywords

BUSULFAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LABELING; CHIMERA; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; LIMB PERFUSION; MOUSE; NONHUMAN; SURVIVAL RATE; VASCULARIZATION;

ANIMALIA;

EID: 0037226225     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.21-2-200     Document Type: Article

References (45)

1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984:307:168-170.
2. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-838.
3. Ildstad ST, Wren SM, Bluestone JA et al. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985;162:231-244.
4. Markus PM, Selvaggi G, Cai X et al. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A+B→A) in rats. Cell Transplant 1993;2:345-353.
5. Colson YL, Zadach K, Nalesnik M et al. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995;60:971-980.
6. Sykes M, Szot GL, Swenson KA et al. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997;3:783-787.
7. Gammie JS, Li S, Zeevi A et al. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Circulation 1998;98(suppl):II163-II169.
8. Gandy KL, Weissman IL. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells. Transplantation 1998;65:295-304.
9. Wekerle T, Kurtz J, Ito H et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000;6:464-469.
10. Orloff MS, DeMara EM, Coppage ML et al. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation 1995;59:282-288.
11. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and the kidney - have rational treatment options emerged? Transplantation 1992;53:169-1179.
12. Kushida T, Inaba M. Takeuchi K et al. Treatment of intractable autoirnmune diseases in MRL/Ipr mice using a new strategy for allogeneic bone marrow transplantation. Blood 2000;95:1862-1868.
13. Kushida T, Inaba M, Hisha H et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/Ipr mice. Blood 2001;97:3292-3299.
14. Askenasy N. Localized bone marrow transplantation leads to skin allograft acceptance in non-myeloablated recipients: comparison of intra-bone marrow and isolated limb perfusiorl. STEM CELLS 2002;20:86-93.
15. Martin PJ. Determinants of engraftment after allogeneic marrow transplantation. Blood 1992;79:1647-1650.
16. Stewart FM, Crittenden RB, Lowry PA et al. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993;81:2566-2571.
17. Bachar-Lustig E, Rachamim N, Li HW et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995;1:1268-1273.
18. + cell transplants. Exp Hematol 2000;28:119-127.
19. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983;309:1347-1353.
20. Brodsky I, Bulova S, Crilley P. The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation. Cancer Invest 1989;7:509-513.
21. Basch RS, Quito FL, Beh J et al. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. STEM CELLS 1997;15:314-323.
22. Askenasy N, Vivi A, Tassini M et al. Cardiac energetics, cell volumes, sodium fluxes, and membrane permeability: NMR studies studies of cold ischemia. Am J Physiol 1995;269:H1056-H1064.
23. Askenasy N, Koretsky AP. Transgenic livers expressing mitochondrial and cytosolic CK: mitochondrial CK modulates free ADP levels. Am J Physiol Cell Physiol 2002;282:C338-C346.
24. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-229.
25. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
26. Okada S, Nakauchi H, Nagayoshi K et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706-1712.
27. Klicks RJ, Vrouenraets BC, Nieweg OE et al. Vascular complications of isolated limb perfusion. Eur J Surg Oncol 1998;24:288-291.
28. Tominaga R, Kohno H, Mayumi H et al. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma. Surg Today 2000;30:339-342.
29. Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol 1999;9:233-238.
30. Askenasy N, Farkas DL. Antigen barriers of available space do not restrict in situ adhesion of hemopoietic cells to bone marrow stroma. STEM CELLs 2002;20:80-85.
31. Micklem HS, Ogden DA, Evans EP et al. Compartments and cell flows within the mouse haemopoietic system. II. Estimated rates of interchange. Cell Tissue Kinet 1975;8:233-248.
32. Boggs DR. The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol 1984; 16:277-286.
33. Wright DE, Wagers AJ, Gulati AP et al. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-1936.
34. Micklem HS, Ford CE, Evans EP et al. Compartments and cell flows within the mouse haemopoietic system. I. Restricted interchange between haemopoietic sites. Cell Tissue Kinet 1975;8:219-232.
35. Maloney MA, Patt HM. Migration of cells from shielded to irradiated marrow. Blood 1972;39:804-808.
36. Mauch P, Down JD, Warhol M et al. Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation 1988;46:205-210.
37. Yeager AM, Shinn C, Pardoll DM. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood 1991;78:3312-3316.
38. Down JD, Ploemacher RE. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp Hematol 1993;21:913-921.
39. Pierce GE, Watts LM, Clancy Jr J. Sublethal fractionated total-body irradiation and donor bone marrow infusion for induction of allograft tolerance. Transplantation 1985;39:236-241.
40. Down JD, Tarbell NJ, Thames HD et al. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 1991;77:661-669.
41. Colson YL, Wren SM, Schuchert MJ et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoetic histocompatibility barriers. J Immunol 1995;155:4179-4188.
42. Schraffordt Koops H, Oldhoff J, van der Ploeg E et al. Isolated regional perfusion in the treatment of malignant melanomas of the extremities. Arch Chir Neerl 1975;27:237-243.
43. Hoffman AL, Makowka L, Cramer DV et al. Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery 1989;106:354-363.
44. Vallera DA, Blazar BR. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 1989;47:751-760.
45. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 1999;11:579-590.